Cite

    Larysa Sanchez et al.. “Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.” Expert review of hematology, vol. 13, no. 9, 2020, pp. 943–958. http://access.bl.uk/ark:/81055/vdc_100113075825.0x000013